Posts

We develop model systems for experimental evolution to design novel treatment strategies that prevent and control the emergence of drug resistance.

We create Machine Learning methods integrated with mechanistic modelling based on statistical physics, spatial tissue simulations and stochastic branching processes.

We use molecular information to quantify and predict tumour evolution in humans and patient-derived models.